American Oriental Bioeng - Comparative Multiple Analysis

American Oriental Bioeng (Comparative Multiple Analysis)


Notes on the Comparative Multiple Analysis of American Oriental Bioeng

WikiWealth compares American Oriental Bioeng's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with American Oriental Bioeng's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for American Oriental Bioeng.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to American Oriental Bioeng's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for American Oriental Bioeng's Analysis

How does this work? The Comparative Investment Analysis determines the value of American Oriental Bioeng by comparing American Oriental Bioeng financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of American Oriental Bioeng.

See the American Oriental Bioeng cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in American Oriental Bioeng.

Also, see the American Oriental Bioeng's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and American Oriental Bioeng's valuation conclusion for a quick summary.